Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

XiAP Associated Factor 1 (XAF1) (Middle Region) Peptid

XAF1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5671967

Kurzübersicht für XiAP Associated Factor 1 (XAF1) (Middle Region) Peptid (ABIN5671967)

Target

XAF1 (XiAP Associated Factor 1 (XAF1))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    KTLDPLLMSE PKPRTSSPRG DKAAYDILRR CSQCGILLPL PILNQHQEKC

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti- XAF1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    XAF1 (XiAP Associated Factor 1 (XAF1))

    Hintergrund

    This gene encodes a protein which binds to and counteracts the inhibitory effect of a member of the IAP (inhibitor of apoptosis) protein family. IAP proteins bind to and inhibit caspases which are activated during apoptosis. The proportion of IAPs and proteins which interfere with their activity, such as the encoded protein, affect the progress of the apoptosis signaling pathway. Multiple transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: BIRC4BP, XIAPAF1, HSXIAPAF1

    Protein Size: 301

    Gen-ID

    54739

    NCBI Accession

    NM_017523, NP_059993

    UniProt

    Q6GPH4
Sie sind hier:
Chat with us!